Recombinant FGF21 Attenuates Polychlorinated Biphenyl-Induced NAFLD/NASH by Modulating Hepatic Lipocalin-2 Expression. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.